Inovio Pharmaceuticals
INO
#8784
Rank
C$0.21 B
Marketcap
C$3.15
Share price
-3.80%
Change (1 day)
18.09%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): C-$3.98

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C-$3.97. In 2024 the company made an earnings per share (EPS) of C-$5.45 an increase over its 2023 EPS that were of C-$8.40.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$3.98-27.01%
2024C-$5.45-35.14%
2023C-$8.40-56.62%
2022C-$19.38-19.54%
2021C-$24.0835.9%
2020C-$17.72-11.57%
2019C-$20.0415.24%
2018C-$17.39-2.78%
2017C-$17.896.93%
2016C-$16.73134.88%
2015C-$7.12-29.51%
2014C-$10.10-57.34%
2013C-$23.68146.55%
2012C-$9.6120.83%
2011C-$7.95-29.41%
2010C-$11.26-48.48%
2009C-$21.8610%
2008C-$19.8711.11%
2007C-$17.89-41.3%
2006C-$30.47-66.91%
2005C-$92.08110.61%
2004C-$43.72-61.63%
2003C-$113.94186.67%
2002C-$39.75
2001N/A-100%
2000C-$31.80-63.64%
1999C-$87.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$2.37-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$14.41-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
C-$1.73-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$10.16-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
C$10.48-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$4.96-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
C$9.00-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA